Sonnet BioTherapeutics, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • CEO Corner
  • Technology
    • Overview
    • Platform
    • Publications
  • Pipeline
    • Overview
    • SON-1010
    • SON-1210
    • SON-080
    • Clinical Trials
  • Partnering
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact

Publications

Technology

Technology

  • Overview
  • Platform
  • Publications

In vivo Effect of Albumin Binding Domains (ABD) Attached to Immune Modulators

November 2017

Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting

View Publication

Enhanced Efficacy of Immune Modulators with Albumin Binding Domains (ABD)

October 2017

Presented at American Association of Cancer Research (AACR) Annual Meeting

View Publication

RSS
  • « Previous
  • 1
  • 2
© 2025 Sonnet BioTherapeutics, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap